SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases
Nastya Kharlamova, Nicky Dunn, Sahl K Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, Iva Gunnarsson, Johan Rönnelid, Rille Pullerits, Inger Gjertsson, Karin Lundberg, Anna Månberg, Elisa Pin, Peter Nilsson, Sophia Hober, Katharina Fink, View ORCID ProfileAnna Fogdell-Hahn
doi: https://doi.org/10.1101/2020.11.13.20231076
Nastya Kharlamova
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Center for Molecular Medicine, Stockholm, Sweden
Nicky Dunn
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Center for Molecular Medicine, Stockholm, Sweden
Sahl K Bedri
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Center for Molecular Medicine, Stockholm, Sweden
Svante Jerling
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Center for Molecular Medicine, Stockholm, Sweden
Malin Almgren
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Center for Molecular Medicine, Stockholm, Sweden
Francesca Faustini
4Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden
Iva Gunnarsson
4Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden
Johan Rönnelid
5Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Rille Pullerits
6Department of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
7Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Inger Gjertsson
6Department of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Karin Lundberg
2Center for Molecular Medicine, Stockholm, Sweden
4Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden
Anna Månberg
8Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Elisa Pin
8Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Peter Nilsson
8Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Sophia Hober
9Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
Katharina Fink
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
3Department of Neurology, Karolinska University Hospital, Stockholm, Sweden
10Centrum for Neurology, Academical Specialist Centrum, Stockholm, Sweden
Anna Fogdell-Hahn
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Center for Molecular Medicine, Stockholm, Sweden
Data Availability
The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Posted November 13, 2020.
SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases
Nastya Kharlamova, Nicky Dunn, Sahl K Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, Iva Gunnarsson, Johan Rönnelid, Rille Pullerits, Inger Gjertsson, Karin Lundberg, Anna Månberg, Elisa Pin, Peter Nilsson, Sophia Hober, Katharina Fink, Anna Fogdell-Hahn
medRxiv 2020.11.13.20231076; doi: https://doi.org/10.1101/2020.11.13.20231076
SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases
Nastya Kharlamova, Nicky Dunn, Sahl K Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, Iva Gunnarsson, Johan Rönnelid, Rille Pullerits, Inger Gjertsson, Karin Lundberg, Anna Månberg, Elisa Pin, Peter Nilsson, Sophia Hober, Katharina Fink, Anna Fogdell-Hahn
medRxiv 2020.11.13.20231076; doi: https://doi.org/10.1101/2020.11.13.20231076
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (162)
- Cardiovascular Medicine (2359)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11748)
- Forensic Medicine (10)
- Gastroenterology (700)
- Genetic and Genomic Medicine (3714)
- Geriatric Medicine (348)
- Health Economics (632)
- Health Informatics (2385)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (776)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3477)
- Nursing (197)
- Nutrition (522)
- Oncology (1813)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1028)
- Primary Care Research (417)
- Public and Global Health (6122)
- Radiology and Imaging (1270)
- Respiratory Medicine (825)
- Rheumatology (379)
- Sports Medicine (320)
- Surgery (398)
- Toxicology (50)
- Transplantation (171)
- Urology (145)